Optometry News

Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.

SEATTLE — The phase 2 PAVIA trial investigating Duravyu, previously known as EYP-1901, for the treatment of nonproliferative diabetic retinopathy did not meet its primary endpoint, according to a press release from EyePoint Pharmaceuticals.

SEATTLE — Funding from the Chronic Disease Foundation impacts the decision to stay on a chosen therapy in patients with age-related macular degeneration, according to a poster presentation.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Marjorie Rah, OD, PhD, FAAO, discusses a poster that investigated Biotrue Hydration Plus Multipurpose solution from Bausch + Lomb.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF therapy for the treatment of proliferative sickle cell retinopathy.

The Contact Lens Institute has published a new report on actions that eye care practices can take to attract potential and former contact lens wearers.

SEATTLE — Black patients with idiopathic intracranial hypertension, or IIH, have greater odds of developing visual impairment, according to research presented at the Association for Research in Vision and Ophthalmology meeting.

SEATTLE — Patient demographic information does not affect the readability of myopia education materials produced by ChatGPT 3.5, but it may affect the length of the material, according to a study.

Among individuals with a history of uveitis, COVID-19 vaccination was linked to an increased risk for recurrent uveitis, particularly in the first month after vaccination, according to a study published in JAMA Ophthalmology.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Mengyu Wang, PhD, discusses vision and language modeling for better glaucoma screening.